๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Comparative Effects of Global Postural Re-education and NASM-based Corrective Exercises in Patients With Upper Cross Syndrome (UCS)

RecruitingNAAges 20 Years - 45 YearsAllRehana Hayat
NCT07528248 on ClinicalTrials.gov โ†—
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to learn the comparative effects of Global postural re-education (GPR) and National Academy of Sports Medicine (NASM) based corrective exercises in participants with upper cross syndrome (UCS). The main questions it aims to answer: * Is there any difference between the effects of GPR and NASM-based corrective exercises in decreasing pain and disability and improving endurance in participants with upper cross syndrome? * Is there any difference between the effects of GPR and NASM-based corrective exercises in improving cranio-vertebral angle of participants with upper cross syndrome? Researchers will compare GPR and NASM-based corrective exercises to see if there is difference between the two treatments in decreasing pain, disability and improving endurance and cranio-vertebral angle. Participants will be: * Given treatment 3 times a week for 8 weeks.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Age between 20-45 years 2. Pain in the upper back and neck region. 3. Both male and female patients 4. Rounded shoulders 5. Craniovertebral angle less than 47 degrees 6. Willingness to participate Exclusion Criteria: 1. History of spinal surgery 2. Neurological deficits (radiculopathy, myelopathy, disc herniation) 3. Severe scoliosis or structural deformity 4. Active cervical spine pathology (spondylosis, stenosis and fracture)
๐Ÿ’Š

What it tests

  • Global Postural Re-education
  • NASM-based Corrective exercises
๐Ÿ“

Where

1 site
District Headquarter Hospital (DHQ) Okara
Okฤra, Pakistan
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy